Allogeneic Stem Cell Transplantation Market, By Source, By Application, By End User, By Cell Type, By Geography

Description

The allogeneic stem cell transplantation market size is expected to reach US$ 6.62 Bn by 2030, from US$ 3.90 Bn in 2023, at a CAGR of 7.8% during the forecast period.

Report Coverage		Report Details
Base Year:	2022	Market Size in 2023:	US$ 3.90 Bn
Historical Data for:	2018 to 2021	Forecast Period:	2023 - 2030
Forecast Period 2023 to 2030 CAGR:	7.80%	2030 Value Projection:	US$ 6.62 Bn

Figure 1. Global Allogeneic Stem Cell Transplantation Market Share (%), By Region, 2023

Allogeneic Stem Cell Transplantation Market - IMG1

Allogeneic stem cell transplantation is a medical procedure that involves the transfer of stem cells from a donor to a recipient. These stem cells can be obtained from various sources such as bone marrow, peripheral blood, or umbilical cord blood. The aim of this procedure is to replace damaged or diseased cells with healthy ones, thereby restoring the function of the recipient's organs or tissues. Allogeneic stem cell transplantation has been used for the treatment of a wide range of conditions including cancers, genetic disorders, and certain immune system disorders.

The global allogeneic stem cell transplantation market is witnessing significant growth due to the increasing prevalence of diseases that can be treated through this procedure. Moreover, advancements in transplantation techniques, as well as the development of new therapeutic approaches, are further contributing to the market growth. The market is characterized by the presence of several key players including Celgene Corporation, Mesoblast Ltd., Pluristem Therapeutics Inc., and Takeda Pharmaceutical Company Limited, among others.

Market Dynamics:

The market dynamics of the allogeneic stem cell transplantation market can be analyzed through the drivers, restraints, and opportunities that shape the market.

Drivers: The increasing incidence of diseases that require stem cell transplantation, such as leukemia, lymphoma, and multiple myeloma, is a major driver for the market. Additionally, the growing geriatric population, advancements in transplantation techniques, and the rise in stem cell banking facilities are also fueling the market growth.
Restraints: The high costs associated with stem cell transplantation procedures and the risk of complications, such as graft-versus-host disease, act as significant restraints for the market. Moreover, the lack of awareness about the potential benefits of allogeneic stem cell transplantation in certain regions hinders the market growth.
Opportunities: The development of innovative therapies and the exploration of new applications for allogeneic stem cell transplantation present significant growth opportunities. Moreover, increasing investments in research and development activities and collaborations between key players and research institutions can drive the market growth.

Key Features of the Study:

This report provides an in-depth analysis of the global allogeneic stem cell transplantation market, including market size (US$ Bn) and Compound Annual Growth Rate (CAGR %) for the forecast period (2023-2030), considering 2022 as the base year
It highlights potential revenue growth opportunities across different market segments and explains attractive investment proposition matrices for this market
The study offers key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
Key players in the global allogeneic stem cell transplantation market include Celgene Corporation, Mesoblast Ltd., Pluristem Therapeutics Inc., and Takeda Pharmaceutical Company Limited, and they are profiled based on company highlights, product portfolios, key highlights, financial performance, and strategies
The report provides valuable information to marketers and management authorities, enabling them to make informed decisions regarding future product launches, market expansion, and marketing tactics
It caters to various stakeholders in the industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts, providing them with insights for decision-making
Stakeholders can benefit from the various strategy matrices used in analyzing the global allogeneic stem cell transplantation market, enhancing ease in decision-making processes

Allogeneic Stem Cell Transplantation Market Segmentation:

By Source
- Bone Marrow
- Peripheral Blood
- Umbilical Cord Blood
- Adipose Tissue
- Dental Pulp
- Others
By Application
- Cancer
- Autoimmune Diseases
- Blood Disorders
- Cardiac Disorders
- Neurological Disorders
- Diabetes
- Others
By End User
- Hospitals
- Research Institutes
- Specialty Clinics
- Others
By Cell Type
- Allogeneic MSCs
- Allogeneic HSCs
- Others
By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East
- Africa
Top Companies in the Allogeneic Stem Cell Transplantation Market:
- Celgene Corporation
- Mesoblast Ltd.
- Pluristem Therapeutics Inc.
- MEDIPOST Co., Ltd.
- Osiris Therapeutics, Inc.
- Cynata Therapeutics Limited
- Takeda Pharmaceutical Company Limited
- Astellas Pharma Inc.
- Cellular Biomedicine Group, Inc.
- Biosolution Co., Ltd.
- StemCell Technologies Inc.
- Caladrius Biosciences, Inc.
- TiGenix N.V.
- ViaCord
- Vericel Corporation
- Regen Biopharma Inc.
- Gamida Cell Ltd.
- Histogenics Corporation
- BrainStorm Cell Therapeutics Inc.
- Lineage Cell Therapeutics, Inc.

Product Code: CMI6407

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Allogeneic Stem Cell Transplantation Market , By Source
- Allogeneic Stem Cell Transplantation Market , By Cell Type
- Allogeneic Stem Cell Transplantation Market , By Application
- Allogeneic Stem Cell Transplantation Market , By End User
- Allogeneic Stem Cell Transplantation Market , By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
Rising incidence of chronic diseases
- Restraints
High costs associated with cell therapies
- Opportunities
Increasing use of allogeneic MSCs
Impact Analysis
Key Highlights
Regulatory Scenario
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Merger and Acquisition Scenario

4. Allogeneic Stem Cell Transplantation Market - Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Allogeneic Stem Cell Transplantation Market, By Source, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Bone Marrow
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Peripheral Blood
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Umbilical Cord Blood
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Adipose Tissue
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Dental Pulp
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

6. Allogeneic Stem Cell Transplantation Market, By Cell Type, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Allogeneic MSCs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion)
Allogeneic HSCs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion)

7. Allogeneic Stem Cell Transplantation Market, By Application, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Cancer
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion)
Autoimmune Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion)
Blood Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion)
Cardiac Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion)
Neurological Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion)
Diabetes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion)

8. Allogeneic Stem Cell Transplantation Market, By End User, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, 2019 - 2030
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion)
Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion)
Specialty Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion)
Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Billion)

9. Allogeneic Stem Cell Transplantation Market, By Region, 2018-2030, (US$ Bn)

Introduction
- Market Share Analysis, By Region, 2023 and 2030 (%)
- Y-o-Y Growth Analysis, For Region, 2018 - 2030
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
U.S.
Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
U.K.
Germany
Italy
France
Spain
Russia
Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
China
India
Japan
ASEAN
Australia
South Korea
Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
Brazil
Mexico
Argentina
Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2018-2030,(US$ Bn)
GCC
Israel
Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Source, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Cell Type, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Application, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2018-2030,(US$ Bn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018-2030,(US$ Bn)
North Africa
Central Africa
South Africa

10. Competitive Landscape

Celgene Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
Mesoblast Ltd.
Pluristem Therapeutics Inc.
MEDIPOST Co., Ltd.
Osiris Therapeutics, Inc.
Cynata Therapeutics Limited
Takeda Pharmaceutical Company Limited
Astellas Pharma Inc.
Cellular Biomedicine Group, Inc.
Biosolution Co., Ltd.
StemCell Technologies Inc.
Caladrius Biosciences, Inc.
TiGenix N.V.
ViaCord
Vericel Corporation
Regen Biopharma Inc.
Gamida Cell Ltd.
Histogenics Corporation
BrainStorm Cell Therapeutics Inc.
Lineage Cell Therapeutics, Inc.
Analyst Views

11. Section

Research Methodology
About us